---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-052467"
form_type: "8-K"
ticker: "QSI"
cik: "0001816431"
company_name: "Quantum-Si Inc"
filed_at: "2023-11-09T23:59:59+00:00"
generated_at: "2026-06-08T07:25:19.943830+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Quantum-Si Q3 2023: $223k revenue, $24.7M net loss; controlled launch continues

## Summary
- Revenue of $223,000; gross profit $108,000 (48% margin); net loss $24.7M vs. $31.7M YoY.
- Adjusted EBITDA loss of $22.6M; adjusted operating expenses $23.9M.
- Completed R&D strategic review; focused on delivering capabilities with highest customer demand.
- First customer data presented; full commercial launch of Platinum instrument expected early 2024.
- Appointed Amir Jafri as independent director, strengthening Board.

## SEC filing metadata
- accession: 0001140361-23-052467
- form_type: 8-K
- ticker: QSI
- cik: 0001816431
- company_name: Quantum-Si Inc
- filed_at: 2023-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816431/000114036123052467/0001140361-23-052467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816431/000114036123052467/ef20014055_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-052467
- JSON: https://secwatch.observer/filing/0001140361-23-052467.json
- Plain text: https://secwatch.observer/filing/0001140361-23-052467.txt

## Key facts
- Earnings Releases
  Quantum-Si Inc reported the third quarter ended September 30, 2023 results: revenue revenue of $223,000, net income Net loss was $24.7 million.
  - Period: the third quarter ended September 30, 2023
  - Revenue: revenue of $223,000
  - Net income: Net loss was $24.7 million
  - Result: reported results
  source text: “Company”), The Protein Sequencing Company TM , today announced financial results for the third quarter ended September 30, 2023. Third Quarter Highlights ● Recorded revenue of $223,000 in the third quarter of 2023 as the Company continued its previously communicated controlled commercial launch of its Platinum instrument ● Completed a strategic review of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816431/000114036123052467/0001140361-23-052467-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.